Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes

Sep.23
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.

Key Points

  • Germany's parliament is scheduled to hold a first reading on September 24 of proposed amendments to the Tobacco Tax Act.
  • The government plans annual increases from 2027 through 2030, with cigarette tax rising to 28.77 euro cents per stick, heated tobacco to 23.12 cents and vaping-liquid duty to €0.36 per ml by 2030.
  • The government forecasts €756 million in additional tobacco-tax revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030.
  • BVTE's campaign is backed by BAT, JTI Germany, Philip Morris Germany and Reemtsma, as January-August tobacco-tax receipts fell 10.8% year over year.

2Firsts

September 23, 2026

Germany's Bundestag is scheduled to hold a first reading on September 24 of proposed amendments to the Tobacco Tax Act that would raise taxes on cigarettes, heated tobacco, vaping liquids and other tobacco products annually from 2027 through 2030.

Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched its "Tabaksteuer mit Augenmaß" initiative on September 21, calling for changes to the government's proposed tax trajectory.

The campaign is backed by British American Tobacco's German business, JT International Germany, Philip Morris Germany, Imperial Brands-owned Reemtsma and German tobacco wholesale, vending and retail associations.

Germany Plans Four Annual Tax Increases

Germany's federal cabinet approved the draft amendments on July 6.

Under the Finance Ministry proposal, major tobacco and nicotine-product tax rates would rise on January 1 of each year from 2027 through 2030.

ProductCurrent2027202820292030
Cigarettes20.27 euro cents/stick22.2124.2126.3928.77
Heated tobacco16.65 euro cents/stick18.1519.6721.3223.12
Vaping liquids and other tobacco substitutes€0.32/ml€0.33€0.34€0.35€0.36/ml
Fine-cut tobacco€100.76/kg€118.90€140.99€172.40€210.51/kg

The nominal increases vary substantially by category.

Vaping-liquid duty would rise about 12.5% from its current level through 2030, compared with roughly 42% for the average cigarette tax burden and about 39% for heated tobacco. Fine-cut tobacco duty would more than double.

Government Forecasts €3.589 Billion in Additional Annual Revenue by 2030

The government bill submitted to the Bundestag estimates that the reform would generate €756 million in additional tobacco-tax revenue in 2027.

By 2030, the additional annual revenue is projected to reach €3.589 billion.

The government says the changes are intended to support federal budget consolidation while also contributing to public-health goals, including lower smoking rates among adults and young people.

The Finance Ministry estimates that if manufacturers and importers pass the higher tax burden through to consumers, the average price of a 20-cigarette pack could rise from about €8.05 currently to:

  • about €8.77 in 2027;
  • €9.56 in 2028;
  • €10.42 in 2029;
  • and about €11.36 in 2030.

Actual retail prices remain set by manufacturers and importers.

BAT, JTI, PMI and Reemtsma Back Industry Campaign

BVTE launched "Tabaksteuer mit Augenmaß" on September 21, calling for smaller and more predictable tax increases.

The campaign focuses on government revenue, illicit trade, consumer costs, legal retail and tax differentiation across product categories.

JTI Germany separately backed the initiative through its official LinkedIn account, saying it addresses the potential effects of the proposed increases on legal trade, cross-border purchasing and illicit markets.

BVTE argues that larger increases could shift more consumers toward cross-border or illegal supply and reduce sales through Germany's legal wholesale and retail channels.

Germany's federal lobbying register also shows BAT, JTI Germany, Philip Morris, Reemtsma and BVTE engaging on the Tobacco Tax Act amendments, with positions including limits on the proposed 2027-2030 increases, adjustments to tax treatment across categories and formal taxation of tobacco-free nicotine pouches.

Industry Pushes for Wider Tax Differentiation

The government proposal already applies different tax rates and trajectories across categories.

Vaping-liquid duty, for example, would rise from €0.32 per ml to €0.36 by 2030, a smaller percentage increase than those proposed for cigarettes and heated tobacco.

BVTE is seeking wider differentiation and says taxation should more strongly reflect differences in product characteristics and risk profiles.

The campaign is also calling for tobacco-free nicotine pouches to be brought into Germany's formal regulatory and tax framework.

BVTE says around 1.5 million people in Germany use nicotine pouches and that 20 of the EU's 27 member states have established regulatory frameworks for the category.

It estimates that a legal and taxed nicotine-pouch market in Germany could generate around €400 million to €500 million in annual tax revenue.

Those figures are BVTE estimates rather than German government forecasts.

Tobacco-Tax Revenue Down 10.8% Through August

German Finance Ministry data show cash tobacco-tax revenue totaled €9.789 billion from January through August 2026, down from €10.975 billion a year earlier, a 10.8% year-over-year decline.

August revenue alone was €1.247 billion, down 5.4%.

Germany's full-year 2026 tobacco-tax budget target is €16.890 billion.

BVTE also says tax-paid cigarette volume fell to about 40.6 billion sticks in the first eight months of 2026 from 46.5 billion a year earlier, a decline of 12.6%.

The industry is citing lower legal-market volume and tax receipts in arguing against steeper increases. The Finance Ministry's published revenue figures do not assign a single cause to the decline.

Bundestag First Reading Scheduled for September 24

The Bundestag has placed the Tobacco Tax Act amendment on its September 24 agenda.

Following the first reading, the bill is expected to be referred to parliamentary committees, with the Finance Committee serving as the lead committee.

If approved, the first round of new rates is scheduled to take effect on January 1, 2027.

Germany's domestic reform is moving in parallel with a broader European Union tobacco-tax overhaul.

The European Commission proposed changes to the Tobacco Excise Directive in July 2025 that would more systematically bring vaping liquids, heated tobacco and nicotine pouches into the EU minimum excise framework.

Germany's Finance Ministry says the domestic proposal is also intended to support negotiations at EU level. National tax rates and legislation could be adjusted again if the revised EU directive is ultimately adopted.

Follow 2Firsts for timely updates on global tobacco and nicotine taxation, regulatory developments and market trends.

Cover Image: BVTE / Tabaksteuer mit Augenmaß


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
The Irish presidency of the Council of the European Union is using bilateral talks to push the bloc’s Tobacco Taxation Directive toward a political agreement in November. According to Law360, citing an EU official, Sweden is unwilling to accept a minimum excise threshold above €20 per kilogram for nicotine pouches. Council negotiations have already lowered the European Commission’s original proposal, but a May 2026 presidency compromise still set the minimum at 10% of the tax-inclusive retail price or €30 per kilogram in 2028-29, with higher levels later.
Market
Sep.17 by 2Firsts Perspectives
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean lawmaker Jeong Jin-wook has again called for stronger government action against liquid synthetic nicotine vape manufacturers and sellers, alleging that some businesses may have avoided regulation through product labeling changes and corporate restructuring. According to Newsworks, JNILBO and other Korean reports, Jeong has held his third press conference on the issue, calling for a government-wide investigation. The dispute involves whether synthetic nicotine products should fall under tobacco regulations, tax implications and supply-chain transparency. South Korean government agencies have previously said some estimates of potential tax losses cannot be verified due to limited sales data.
Jul.27
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08